ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

Includes June issue of Business & Regulatory Report.

June 28, 2002

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis

June 25, 1976

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013